Prediction of severe lymphopenia during chemoradiotherapy for esophageal cancer

被引：0
|
作者：
Van Rossum, P. [1 ,2 ]
Deng, W. [2 ]
Routman, D. [3 ]
Liu, A. [4 ]
Xu, C. [2 ]
Shiraishi, Y. [2 ]
Peters, M. [1 ]
Merrell, K. [3 ]
Hallemeier, C. [3 ]
Mohan, R. [4 ]
Lin, S. [2 ]
机构：
[1] UMC Utrecht, Radiat Oncol, Utrecht, Netherlands
[2] Univ Texas MD Anderson Canc Ctr, Radiat Oncol, Houston, TX 77030 USA
[3] Mayo Clin, Radiat Oncol, Rochester, MN USA
[4] Univ Texas MD Anderson Canc Ctr, Radiat Phys, Houston, TX 77030 USA
来源：
RADIOTHERAPY AND ONCOLOGY | 2019年 / 133卷
关键词：
D O I：
10.1016/S0167-8140(19)31215-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-0795
引用
收藏
页码：S411 / S411
页数：1
相关论文
共 50 条
  • [11] Effectiveness of Chemoradiotherapy for Esophageal Cancer With Severe Stenosis
    Kondo, Shinya
    Tajika, Masahiro
    Tanaka, Tsutomu
    Kodaira, Takeshi
    Mizuno, Nobumasa
    Hara, Kazuo
    Hijioka, Susumu
    Imaoka, Hiroshi
    Nagashio, Yoshikuni
    Hasegawa, Toshiyuki
    Obayashi, Tomohiko
    Shinagawa, Akihide
    Sekine, Masanari
    Goto, Hidemi
    Ando, Takafumi
    Yamao, Kenji
    Niwa, Yasumasa
    GASTROENTEROLOGY, 2013, 144 (05) : S517 - S517
  • [12] Inflammation with Lymphopenia During Chemoradiotherapy Predicts Recurrence and Mortality in Locally Advanced Esophageal Carcinoma
    Sherry, A. D.
    Newman, N. B.
    Anderson, J. L.
    Osmundson, E. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E197 - E197
  • [13] The impact of the effective dose to immune cells on lymphopenia and survival of esophageal cancer after chemoradiotherapy
    Xu, Cai
    Jin, Jian-Yue
    Zhang, Ming
    Liu, Amy
    Wang, Jun
    Mohan, Radhe
    Kong, Fengming
    Lin, Steven H.
    RADIOTHERAPY AND ONCOLOGY, 2020, 146 : 180 - 186
  • [14] Early Onset of Severe Lymphopenia During Definitive Concurrent Chemoradiotherapy Predicts Poor Survival in Patients with Cervical Cancer
    Xu, Z.
    Yang, L.
    Chang, A. T.
    Nong, Y. Q.
    Wang, Q.
    Hui, S. K.
    Lee, K. W.
    Chan, W.
    Zhou, Y.
    Zhang, H.
    Jin, J. Y.
    Kong, F. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E484 - E484
  • [15] Spleen Dose-Volume Parameters as a Predictor of Treatment-related Lymphopenia During Definitive Chemoradiotherapy for Esophageal Cancer
    Saito, Tetsuo
    Toya, Ryo
    Yoshida, Naoya
    Shono, Takashi
    Matsuyama, Tomohiko
    Ninomura, Satoshi
    Watakabe, Takahiro
    Sasaki, Yutaka
    Baba, Hideo
    Oya, Natsuo
    IN VIVO, 2018, 32 (06): : 1519 - 1525
  • [16] Treatment regimen is an independent predictor for severe lymphopenia in esophageal cancer patients
    Muijs, Christina T.
    Visser, Sabine
    Beukema, Jannet C.
    De Haan, Jacco
    Van Etten, Boudewijn
    Korevaar, Erik
    Schuit, Ewoud
    Langendijk, Johannes A.
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S2189 - S2191
  • [17] Prediction of delayed lymphopenia after chemoradiotherapy in non-small cell lung cancer
    Kang, B.
    Lee, J. H.
    Xue, L.
    Son, J.
    Wu, H.
    Kim, H. J.
    Kang, H.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S961 - S961
  • [18] Lung dose was associated with severe lymphopenia in esophageal cancer undergoing trimodality therapy
    Lin, J.
    Lee, J.
    Cheng, C.
    Chang, T.
    Chen, Y.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S416 - S416
  • [19] Severe radiation-induced lymphopenia during concurrent chemoradiotherapy for stage III non-small cell lung cancer: external validation of two prediction models
    van Rossum, Peter S. N.
    Juan-Cruz, Celia
    Stam, Barbara
    Rossi, Maddalena M. G.
    Lin, Steven H.
    Abravan, Azadeh
    Belderbos, Jose S. A.
    Sonke, Jan-Jakob
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [20] PET/CT planning during chemoradiotherapy for esophageal cancer
    Seol, Ki Ho
    Lee, Jeong Eun
    RADIATION ONCOLOGY JOURNAL, 2014, 32 (01): : 31 - 42
12345